NGF and Alzheimer disease: Given the complexity of AD, future strategies are likely to adopt a combinatorial approach, coupling BDNF gene therapy with agents that address complementary pathways, such as anti-amyloid antibodies, NGF support for cholinergic neurons, or anti-inflammatory cytokines [37].